Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 3/20 | 0.55 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.45 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2604925 | 1.00 | TRPA1 (0.55) | TRPA1TAAR1SIGMAR1SLC6A2MAOA | |
| SCHEMBL5161982 | 0.86 | TRPA1 (0.58) | TRPA1TAAR1SIGMAR1SLC6A2MAOA | |
| SCHEMBL3077663 | 0.86 | TRPA1 (0.54) | TRPA1TAAR1SIGMAR1SLC6A2MAOA | |
| SCHEMBL13721525 | 0.86 | TRPA1 (0.58) | TRPA1TAAR1SIGMAR1SLC6A2MAOA | |
| SCHEMBL8087389 | 0.86 | TRPA1 (0.54) | TRPA1TAAR1SIGMAR1SLC6A2MAOA | |
| Ammonia Solution, Strong SCHEMBL28248686 | 0.84 | TRPA1 (0.52) | TRPA1TAAR1SIGMAR1SLC6A2MAOA | |
| SCHEMBL14402660 | 0.83 | TRPA1 (0.52) | TRPA1TAAR1SIGMAR1SLC6A2MAOA | |
| SCHEMBL345256 | 0.81 | TRPA1 (0.39) | TRPA1TAAR1SLC6A4CYP2A6CYP1A2 | |
| SCHEMBL12512917 | 0.81 | ESR1 (0.55) | TAAR1SLC6A2SLC6A3CYP1A2CYP3A4 | |
| Acetic Acid SCHEMBL10433402 | 0.81 | ALPI (0.53) | TRPA1CYP1A2TSHRCYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210069071-A1 | COSMETIC SOAP GEL STICKS WITH IMPROVED MANUFACTURABILITY | HENKEL AG & CO. KGAA (DE) | 2021-03-11 | — | — | US | claimed |
| EP-2453867-A2 | COSMETIC AND DERMATOLOGICAL TOPICAL COMPOSITIONS HAVING A HAIR GROWTH-MINIMISING OR HAIR GROWTH-INHIBITING EFFECT | Henkel AG & Co. KGaA (DE) | 2012-05-23 | — | — | EP | claimed |
| EP-2349185-A2 | MORE EFFECTIVE ANHYDROUS DEODORANT COMPOSITIONS APPLIED AS A SPRAY | Henkel AG & Co. KGaA (DE) | 2011-08-03 | — | — | EP | claimed |
| EP-2349184-A2 | MORE EFFECTIVE ANHYDROUS DEODORANT COMPOSITIONS APPLIED AS A NON-AEROSOL | Henkel AG & Co. KGaA (DE) | 2011-08-03 | — | — | EP | claimed |
| WO-2011006689-A2 | COSMETIC AND DERMATOLOGICAL TOPICAL COMPOSITIONS HAVING A HAIR GROWTH-MINIMISING OR HAIR GROWTH-INHIBITING EFFECT | HENKEL AG & CO. KGAA (DE) | 2011-01-20 | — | — | WO | claimed |
| WO-2010009976-A2 | MORE EFFECTIVE ANHYDROUS DEODORANT COMPOSITIONS APPLIED AS A NON-AEROSOL | HENKEL AG & CO. KGAA (DE) | 2010-01-28 | — | — | WO | claimed |
| WO-2010009977-A2 | MORE EFFECTIVE ANHYDROUS DEODORANT COMPOSITIONS APPLIED AS A SPRAY | HENKEL AG & CO. KGAA (DE) | 2010-01-28 | — | — | WO | claimed |
| EP-0799174-A1 | BIOCIDAL ALCOHOLS, THEIR PRODUCTION AND THEIR USE | SCHÜLKE & MAYR GMBH (DE) | 1997-10-08 | — | — | EP | claimed |
| WO-1996019428-A1 | BIOCIDAL ALCOHOLS, THEIR PRODUCTION AND THEIR USE | Schülke & Mayr GmbH (DE) | 1996-06-27 | — | — | WO | claimed |
| US-20250188376-A1 | SUSTAINABLE AVIATION FUELS | SARTEC CORPORATION | 2025-06-12 | — | — | US | disclosed |
| US-20230133671-A1 | SETD2 INHIBITORS AND RELATED METHODS AND USES, INCLUDING COMBINATION THERAPIES | Epizyme, Inc. (US) | 2023-05-04 | — | — | US | disclosed |
| US-20230022157-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT FACTOR D MEDICAL DISORDERS | ACHILLION PHARMACEUTICALS, INC. (US) | 2023-01-26 | — | — | US | disclosed |
| US-11504309-B2 | Deo emulsion for aerosols, deodorant comprising the same and use of the deodorant | HENKEL AG & CO. KGAA (DE) | 2022-11-22 | — | — | US | disclosed |
| US-11324675-B2 | Deo emulsion for aerosols with reduced stain problem, deodorant comprising the same and use of the deodorant | HENKEL AG & CO. KGAA (DE) | 2022-05-10 | — | — | US | disclosed |
| EP-0799174-A1 | BIOCIDAL ALCOHOLS, THEIR PRODUCTION AND THEIR USE | SCHÜLKE & MAYR GMBH (DE) | 1997-10-08 | — | — | EP | disclosed |
| WO-1996019428-A1 | BIOCIDAL ALCOHOLS, THEIR PRODUCTION AND THEIR USE | Schülke & Mayr GmbH (DE) | 1996-06-27 | — | — | WO | disclosed |
| EP-0032576-B1 | PROCESS FOR THE PREPARATION OF P-SUBSTITUTED PHENYL PROPANOLS AND THEIR ESTERS AND OF P-SUBSTITUTED 3-PHENYL-2-METHYL PROPANALS | BASF Aktiengesellschaft (DE) | 1983-08-10 | — | — | EP | disclosed |
| EP-0032576-A1 | Process for the preparation of p-substituted phenyl propanols and their esters and of p-substituted 3-phenyl-2-methyl propanals | BASF Aktiengesellschaft (DE) | 1981-07-29 | — | — | EP | disclosed |
| US-4175544-A | X-RAYS OF BODY FOR MEDICAL DIAGNOSIS | Lafayette Pharmacal Inc. (US) | 1979-11-27 | — | — | US | disclosed |
| US-4022814-A | Iodine containing organic carbonates for use as radiographic agents | LAFAYETTE PHARMACAL, INC. (US) | 1977-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230022157-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT FACTOR D MEDICAL DISORDERS | CFD, CFH, TFPI | TRPA1 3961/4885TAAR1 4621/4885SIGMAR1 4323/4885 |
| US-20230133671-A1 | SETD2 INHIBITORS AND RELATED METHODS AND USES, INCLUDING COMBINATION THERAPIES | EZH2, HDAC2, SETD2 | TRPA1 4838/4885TAAR1 4066/4885SIGMAR1 3209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.